Health care system costs related to potentially inappropriate medication use involving opioids in older adults in Canada

Author:

D’Aiuto Carina,Lunghi Carlotta,Guénette Line,Berbiche Djamal,Bertrand Karine,Vasiliadis Helen-Maria

Abstract

Abstract Background Older adults are at risk of potentially inappropriate medication use given polypharmacy, multimorbidity, and age-related changes, which contribute to the growing burden associated with opioid use. The objective of this study was to estimate the costs of health service utilization attributable to opioid use and potentially inappropriate medication use involving opioids in older adults in a public health care system. Methods The sample included 1201 older adults consulting in primary care, covered by the public drug plan, without a cancer diagnosis and opioid use in the year before interview. Secondary analyses were conducted using two data sources: health survey and provincial administrative data. Health system costs included inpatient and outpatient visits, physician billing, and medication costs. Unit costs were calculated using annual financial and activity reports from 2013–2014, adjusted to 2022 Canadian dollars. Opioid use and potentially inappropriate medication use involving opioids were identified over 3 years. Generalized linear models with gamma distribution were employed to model 3-year costs associated with opioid use and potentially inappropriate medication use involving opioids. A phase-based approach was implemented to provide descriptive results on the costs associated with each phase: i) no use, ii) opioid use, and iii) potentially inappropriate medication use involving opioids. Results Opioid use and potentially inappropriate medication use involving opioids were associated with adjusted 3-year costs of $2,222 (95% CI: $1,179-$3,264) and $8,987 (95% CI: $7,370-$10,605), respectively, compared to no use. In phase-based analyses, costs were the highest during inappropriate use. Conclusions Potentially inappropriate medication use involving opioids is associated with higher costs compared to those observed with opioid use and no use. There is a need for more effective use of health care resources to reduce costs for the health care system.

Funder

Health Canada and the Ministry of Health and Social Services

Fonds de recherche du Québec - Santé

Publisher

Springer Science and Business Media LLC

Subject

Health Policy

Reference51 articles.

1. Canadian Institute for Substance Use Research (CISUR), Canadian Centre on Substance Use and Addiction (CCSA). Canadian substance use costs and harms 2015–2017. 2020. https://csuch.ca/publications/CSUCH-Canadian-Substance-Use-Costs-Harms-Report-2020-en.pdf. Accessed 3 Nov 2020.

2. Canadian Institute for Health Information (CIHI). Hospitalizations and emergency department visits due to opioid poisoning in Canada. 2016. https://secure.cihi.ca/free_products/Opioid%20Poisoning%20Report%20%20EN.pdf. Accessed 27 July 2022.

3. Kwan D, Farrell B. Polypharmacy: optimizing medication use in elderly patients. Can Geriatr Soc J CME. 2014;4(1):7.

4. Clark CM, Shaver AL, Aurelio LA, Feuerstein S, Wahler RG, Daly CJ, et al. Potentially inappropriate medications are associated with increased healthcare utilization and costs. J Am Geriatr Soc. 2020;68(11):2542–50.

5. Hyttinen V, Jyrkkä J, Valtonen H. A systematic review of the impact of potentially inappropriate medication on health care utilization and costs among older adults. Med Care. 2016;54(10):950–64.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3